FDA Panel Endorses Pfizer Shots for 5- to 11-Year-Olds
October 27th, 2021Via: The Defender:
The U.S. Food and Drug Administration’s advisory panel today voted to recommend the agency allow Pfizer to amend its Emergency Use Authorization for its COVID vaccine for children 5 through 11 years old, despite a host of objections from scientists and physicians.